BUD vs. CRON
BUD (Anheuser-Busch InBev SA/NV) and CRON (Cronos Group Inc.) are both stocks. BUD operates in Beverages - Brewers (Consumer Defensive), while CRON operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, BUD returned 2.63%/yr vs -21.36%/yr for CRON. At a 0.22 correlation, their price movements are largely independent.
Performance
BUD vs. CRON - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BUD achieves a 31.39% return, which is significantly higher than CRON's 1.90% return.
BUD
- 1D
- 0.78%
- 1M
- 2.46%
- YTD
- 31.39%
- 6M
- 32.01%
- 1Y
- 18.48%
- 3Y*
- 16.08%
- 5Y*
- 2.63%
- 10Y*
- -1.70%
CRON
- 1D
- -2.55%
- 1M
- 1.90%
- YTD
- 1.90%
- 6M
- -18.04%
- 1Y
- 38.86%
- 3Y*
- 15.05%
- 5Y*
- -21.36%
- 10Y*
- —
BUD vs. CRON - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BUD Anheuser-Busch InBev SA/NV | 31.39% | 30.33% | -21.37% | 9.04% | 0.09% | -12.66% | -13.97% | 27.69% | -38.79% | 9.62% |
CRON Cronos Group Inc. | 1.90% | 30.20% | -3.35% | -17.72% | -35.20% | -43.52% | -9.52% | -26.18% | 34.43% | 600.87% |
Correlation
The correlation between BUD and CRON is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jul 12, 2016 | 0.22 |
The correlation between BUD and CRON shifts across timeframes, from 0.11 (1 year) to 0.26 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
BUD:
$6.15
CRON:
-$0.01
BUD:
1.37
CRON:
3.52
BUD:
$120.38B
CRON:
$220.07M
BUD:
$67.02B
CRON:
$68.18M
BUD:
$35.48B
CRON:
$2.28M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BUD vs. CRON — Risk / Return Rank
BUD
CRON
BUD vs. CRON - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Anheuser-Busch InBev SA/NV (BUD) and Cronos Group Inc. (CRON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BUD | CRON | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.08 | ||
| Sortino ratioReturn per unit of downside risk | -0.49 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.17 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.88 | 1.29 | -0.41 |
| Martin ratioReturn relative to average drawdown | 1.66 | 2.27 | -0.61 |
Loading charts...
Drawdowns
BUD vs. CRON - Drawdown Comparison
The maximum BUD drawdown since its inception was -70.02%, smaller than the maximum CRON drawdown of -93.16%. Use the drawdown chart below to compare losses from any high point for BUD and CRON.
Loading charts...
Drawdown Indicators
| BUD | CRON | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.02% | -93.16% | +23.14% |
Max Drawdown (1Y)Largest decline over 1 year | -20.12% | -26.91% | +6.79% |
Max Drawdown (3Y)Largest decline over 3 years | -31.55% | -46.36% | +14.81% |
Max Drawdown (5Y)Largest decline over 5 years | -42.34% | -82.06% | +39.72% |
Max Drawdown (10Y)Largest decline over 10 years | -70.02% | — | — |
Current DrawdownCurrent decline from peak | -22.81% | -88.69% | +65.88% |
Average DrawdownAverage peak-to-trough decline | -23.45% | -63.61% | +40.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.86% | 15.34% | -4.48% |
Volatility
BUD vs. CRON - Volatility Comparison
The current volatility for Anheuser-Busch InBev SA/NV (BUD) is 6.20%, while Cronos Group Inc. (CRON) has a volatility of 9.44%. This indicates that BUD experiences smaller price fluctuations and is considered to be less risky than CRON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BUD | CRON | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.20% | 9.44% | -3.24% |
Volatility (6M)Calculated over the trailing 6-month period | 17.97% | 30.10% | -12.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.38% | 46.46% | -20.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.90% | 53.86% | -28.96% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.65% | 74.63% | -46.98% |
Dividends
BUD vs. CRON - Dividend Comparison
BUD's dividend yield for the trailing twelve months is around 1.62%, while CRON has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BUD Anheuser-Busch InBev SA/NV | 1.62% | 1.91% | 1.74% | 1.28% | 0.88% | 0.98% | 0.79% | 2.45% | 5.15% | 3.63% | 5.41% | 3.21% |
CRON Cronos Group Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
BUD vs. CRON - Financials Comparison
This section allows you to compare key financial metrics between Anheuser-Busch InBev SA/NV and Cronos Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BUD vs. CRON - Profitability Comparison
BUD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Anheuser-Busch InBev SA/NV reported a gross profit of 17.10B and revenue of 30.61B. Therefore, the gross margin over that period was 55.9%.
CRON - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cronos Group Inc. reported a gross profit of 19.15M and revenue of 58.97M. Therefore, the gross margin over that period was 32.5%.
BUD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Anheuser-Busch InBev SA/NV reported an operating income of 80.56M and revenue of 30.61B, resulting in an operating margin of 0.3%.
CRON - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cronos Group Inc. reported an operating income of -1.83M and revenue of 58.97M, resulting in an operating margin of -3.1%.
BUD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Anheuser-Busch InBev SA/NV reported a net income of 3.01B and revenue of 30.61B, resulting in a net margin of 9.8%.
CRON - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cronos Group Inc. reported a net income of 13.75M and revenue of 58.97M, resulting in a net margin of 23.3%.
Frequently Asked Questions
BUD and CRON have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRON has higher volatility (9.44%) compared to BUD (6.20%). In terms of maximum drawdown, BUD dropped -70.02% vs CRON's -93.16%.
CRON currently has the higher Sharpe Ratio (0.75 vs 0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BUD and CRON
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer